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Abstract
Background: The beneficial effects of highly active antiretroviral therapy, increasing survival and
the prevention of AIDS defining illness development are well established. However, the annual
Portuguese hospital mortality is still higher than expected. It is crucial to understand the
hospitalization behaviour to better allocate resources. This study investigates the predictors of
mortality in HIV associated hospitalizations in Portugal through a hierarchical survival model.
Methods:  The study population consists of 12,078 adult discharges from patients with HIV
infection diagnosis attended at Portuguese hospitals from 2005–2007 that were registered on the
diagnosis-related groups' database.
We used discharge and hospital level variables to develop a hierarchical model. The discharge level
variables were: age, gender, type of admission, type of diagnoses-related group, related HIV
complication, the region of the patient's residence, the number of diagnoses and procedures, the
Euclidean distance from hospital to the centroid of the patient's ward, and if patient lived in the
hospital's catchment area. The hospital characteristics include size and hospital classification
according to the National Health System. Kaplan-Meier plots were used to examine differences in
survival curves. Cox proportional hazard models with frailty were applied to identify independent
predictors of hospital mortality and to calculate hazard ratios (HR).
Results: The Cox proportional model with frailty showed that male gender, older patient, great
number of diagnoses and pneumonia increased the hazard of HIV related hospital mortality. On the
other hand tuberculosis was associated with a reduced risk of death. Central hospital discharge also
presents less risk of mortality.
The frailty variance was small but statistically significant, indicating hazard ratio heterogeneity
among hospitals that varied between 0.67 and 1.34, and resulted in two hospitals with HR different
from the average risk.
Conclusion: The frailty model suggests that there are unmeasured factors affecting mortality in
HIV associated hospitalizations. Consequently, for healthcare policy purposes, hospitals should not
all be treated in an equal manner.
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Background
The introduction of highly active antiretroviral therapy
(HAART) in late 1996 dramatically improved the progno-
sis of Human Immunodeficiency Virus (HIV) infected
patients in most developed countries [1,2]. Consequently,
the estimated number of worldwide deaths due to HIV/
AIDS is declining, which is attributable to the scaling up
of antiretroviral treatment services. Nevertheless, HIV/
AIDS remains a leading cause of mortality throughout the
world. In Portugal, although the access to treatment has
been free of charge since 1996 and available in all hospi-
tals since 2005, there are still an elevated number of
deaths due to HIV/AIDS, namely, in men between 25 and
34 years old [3]. Despite declining mortality over the last
years, adult HIV prevalence in 2007 ranges from 0.1% to
0.6% in Europe. Portugal is one of the European countries
with the highest prevalence (0.5%) [4], where 31,667
cases of HIV/AIDS were notified in 2007 [5].
HIV/AIDS is one of the major financial burdens on
healthcare systems worldwide. In the United States the
average annual HIV/AIDS charge per patient was esti-
mated to be approximately $18,000 from 1996–2000 [6].
In Portugal, hospitalizations related to HIV infection are
also some of the most expensive; the average daily cost is
around €825 and it is the second major diagnosis cate-
gory (MDC) with greater average hospitalization time.
The average length of stay (LOS) in Portuguese hospitals
from the National Health Service (NHS) was 23 days in
2006 [7,8]. Although this value is very high compared to
countries like the USA or Canada, where the average is
around 5 days [6,9], it is similar to European countries
such as Germany where the average LOS is 20 days [10].
In recent literature several approaches have been adopted
to analyse LOS. Barbour et al. [6] used a multivariable lin-
ear regression model to study charges among HIV/AIDS
inpatients. On the other hand, Huang et al. [11] used a
generalized linear mixed model to study LOS and costs,
and Wang et al. [12] adopted a two-component Poisson
mixture model to analyse maternity LOS. In the present
study, LOS will be considered the main vehicle that allows
the study of hospital mortality of HIV infected patients.
In the study of hospital mortality one has to be aware that
the risk of death cannot be assumed to be homogeneous,
but must be considered as a heterogeneous, i.e. a mixture
of individuals with different hazards. In this particular
case, the hospital mortality may vary according to individ-
ual patient and hospital characteristics. The former can be
taken into account by including covariates at the hospital-
ization level in a classical Cox proportional survival
model. Differences in the health services can be assessed
using hierarchical models, including variables at hospital-
ization and hospital levels, allowing the estimate of differ-
ences in outcome not fully explained by observed patient
or other specific and known conditions. The aim of this
paper is to investigate predictors of mortality in HIV asso-
ciated hospitalizations in Portugal. We propose the use of
a hierarchical time survival model to analyse data of HIV
discharges in Portuguese hospitals from 2005 to 2007.
To our knowledge, this is the first study using this type of
methodology for HIV discharges in Portugal. This analysis
is particularly important given the considerable burden
associated with HIV treatment/hospitalization.
Methods
Data source
The data were provided by the Central Administration of
Health System (ACSS) and refer to the Portuguese
national database of the diagnosis related groups (DRG –
All Patients v21.0). The data are anonymous and available
from the ACSS for scientific research. In the DRG database
each record corresponds to a discharge episode (hospital-
ization) and contains information about the patient and
information collected while the patient was in hospital.
Hospital characteristics were obtained from data provided
by ACSS and the Portuguese National Institute of Statis-
tics.
Study Population
Between 1st January 2005 and 31st December 2007 there
were 14,165 discharges registered in Portuguese NHS hos-
pitals. For this study we considered only those that met
the following criteria: hospitalizations classified under the
MDC 24 created for HIV infections patients, which incor-
porates the DRG 700–716; inpatients aged 18 years or
older; geo-referenced cases, i.e., hospitalization with
patient residence ward known; hospitalizations from hos-
pitals with more than 10 discharges; all hospitalizations
were included except those for transfers to another hospi-
tal (to avoid including the inpatient episode twice, given
that often the cause of the transfer was lack of procedure
facilities); and hospitalizations with LOS ≥ 1 day.
With these criteria, we selected 12,078 hospitalizations
occurring in 43 public NHS hospitals (Figure 1).
Dependent variable
The dependent variable was the number of days between
the hospital admission and discharge dates (LOS). Death
was assumed to be the outcome of interest and censoring
was considered when patients were alive at discharge.
Covariates
Discharge level variables
The discharge variables considered in this study were: the
age of the patient on admission, gender, the type ofBMC Health Services Research 2009, 9:125 http://www.biomedcentral.com/1472-6963/9/125
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admission (urgent or planned), the type of DRG (medical
or surgical), the HIV infection related complication
(pneumonia, tuberculosis, pneumocystis pneumonia
(PCP), hepatitis B and C), the patient's residential region
(North, Centre, Lisbon and Tagus valley, and South). Spe-
cific data on income, education, and other components of
socioeconomic status (SES) were not available. Therefore,
we utilized the type of admission variable as a proxy for
SES as in Barbour et al. [6]. The Euclidean distance from
hospital to the centroid of the patient's residential ward in
kilometres was calculated. Whether the patient lived in
the catchment area of the hospital was another distance
covariate. In addition, the number of diagnoses and the
number of procedures undertaken were also available for
each hospitalization. In the exploratory analysis, age,
number of diagnoses and procedures were divided into
two categories according to their median value (age: ≤ 39,
>39 years; number of diagnoses ≤ 5, >5; and number of
procedures ≤ 8, >8). The distance was categorized accord-
ing to its average value of 13 km.
Group-level variables (hospital characteristics)
The following information was available to characterize
the NHS hospital: the hospital size represented by the
number of beds (500 beds maximum and greater than
500 beds); classifications according to NHS administra-
tive structure (hospitals offering more differentiated serv-
ices denoted central).
Statistical analysis
Descriptive statistics were computed for all variables:
means, medians, and standard deviations for continuous
variables, and frequencies and percentages for categorical
variables.
Kaplan-Meier (KM) estimators were applied to estimate
survival curves, and log rank tests and Peto tests were used
for comparison between variables categories.
Cox proportional hazard models [13] were used to iden-
tify independent predictors of hospital mortality and cal-
culate hazard ratios (HR).
To take into account the left truncation of the survival dis-
charge data we adopted the Cox model with a counting
process approach and also included random effects to
deal with covariates hierarchy denoted frailty models.
This random effect can be thought of as a "frailty", increas-
ing hospital's susceptibility to short survival time when it
is large, and decreasing this susceptibility when it is small.
The equation λ (t|x)= zλ0(t)exp(xβ) describes the frailty
model where x are the covariates matrix, β are the fixed
effect vector, and Z is a random variable representing an
unknown random effect, and related to hospitals, with
unit mean and variance ξ. These random effects act multi-
plicatively on the baseline hazard, and large values of ξ
reflect a great degree of heterogeneity among hospitals.
Groups with frailty >1 tend to experience the event at a
faster rate than under the basic Cox model, indicating in
our case a poor hospital performance. On the other hand,
when frailty is <1, survival times tend to be longer. It
should be noted that when the variance of Z approaches
zero, the model reduces to the basic Cox model. For
model distribution purposes, we assumed that the frailties
were distributed according to a gamma distribution [14].
One attractive feature of the gamma distribution is that it
is mathematically tractable. Frailty models were treated as
a penalized Cox model [15] and were estimated using the
survival package from R software.
To build the model, we first included in a classic Cox sur-
vival model only the hospitalization level and group level
variables which were statistically significant at the 10%
level in KM analysis; thereafter the random effects were
added. To compare the Cox model and the Frailty model,
we applied the likelihood ratio (LR) test. All the statistical
analyses were performed using R statistical software [16].
Results
In this study the median LOS was equal to 12 days (inter-
quartile range 6–24). Summary statistics of the hospitali-
zation according to discharge episodes and hospital
characteristics are in Table 1.
Out of 12,078 discharges, 8,954 (74.1%) were male and
the median age was 42 years. The number of discharges
Selection profile of study population Figure 1
Selection profile of study population.BMC Health Services Research 2009, 9:125 http://www.biomedcentral.com/1472-6963/9/125
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decreased 7.8% in the last year of the study. There were
10,281 (85.1%) urgent admissions and the majority of
the discharges (92.7%) had medical DRG. Over the three
years of study, the most common HIV related complica-
tions were pneumonia and tuberculosis, accounting for
19.9% and 18.7% of the discharges, respectively. The end-
point death occurred in 15.2% (1,833) of the hospitaliza-
tions.
KM exploratory analysis suggests that hospitalization
from older patients, men, urgently admitted, and those
with medical DRG were associated with a faster progres-
sion to death (Figure 2).
For these four variables log rank and Peto tests for KM sur-
vival differences were all highly significant (p < 0.001).
Hospitalization with a greater number of diagnoses and
procedures also presented lower survival. The main HIV
related infection complication risk factor for survival was
pneumonia, which is also statistically significant, as can
be seen from Table 2. Patients with tuberculosis showed a
high median survival LOS and this was also statistically
significant. There was no statistically significant difference
between presences or absence of PCP and hepatitis B.
Hepatitis C was statistically significant at the 10% level.
The year of discharge and the patient's residential region
did not yield significant survival differences. Both Eucli-
dean distance and catchment area presented statistically
significant differences in KM survival curves. However,
because they are highly associated and the former did not
represent the real distance between hospital and patient
residence, living in the hospital catchment area was cho-
sen to be included in the survival model as a proxy of res-
idential distance to hospital.
The two hospital characteristics provided KM survival
curves differences statistically significant at the 10% level.
The variables thus selected and included in the model
were: gender, age, type of admission, type of DRG,
number of diagnoses, number of procedures, pneumonia,
tuberculosis, hepatitis C, living in hospital catchment
area, hospital size, and hospital classification. Table 3
shows the HR for each covariate in the Cox survival mod-
els with and without frailty. From the frailty model, men
increase the risk, as expected, by 27.0% in comparison to
women. Each additional year of age leads to an increase in
risk of 1.3%. Urgent admission presents the highest risk,
increasing it by 60% in comparison with programmed
admission. Surgical DRG reduces the risk of death by
44%. Each additional diagnosis raises the hospital mortal-
ity risk by only 2%. Pneumonia is the most serious HIV
related infection complication, raising the risk by 43%,
while tuberculosis presents a protective effect, reducing
the risk by 22%. Hepatitis C and live in hospital catch-
ment area were not important predictors to hospital mor-
tality. Parameter estimates of individual covariates are
quite similar for both models.
Regarding hospital covariates, the hospital size presents
statistical significance only in the Cox model without
frailty. Nonetheless, large hospitals (>500 beds) present a
hazard of 1.14 greater than smaller hospitals. The central
hospital presents statistically significant difference from
non-central hospital in both models and can be consid-
ered to be a protective factor, decreasing the hazard by
20%.
The inclusion of a frailty effect expands the coefficient
95% confidence intervals of the hospital characteristics,
and the hospital size loses statistical significance. The esti-
mated frailty variance (0.032) is statistically significant (p
= 0.002) and indicates the presence of a small variability
among Portuguese NHS hospitals (Figure 3). The hospi-
tals specific HRs, varying from 0.67 to 1.34, are presented
in Figure 3 with their respective 95% confidence interval.
Notably, there is only one hospital with frailty signifi-
cantly greater than 1 and there is also one hospital with
Table 1: Characteristics of HIV discharges in Portuguese NHS 
hospitals
Variables (mean ± sd) n = 12,078
Age; years 41.6 ± 11.5
LOS; days 19.2 ± 24.8
Number of diagnoses 6.2 ± 3.5
Number of procedures 8.2 ± 4.3
Gender (%)
Male 8,954 (74.1)
Female 3,124 (25.9)
Year of discharge (%)
2005 4,111 (34.0)
2006 4,124 (34.2)
2007 3,843 (31.8)
Type of admission (%)
Urgent 10,281 (85.1)
Planned 1,797 (14.9)
Type of DRG (%)
Medical 11,192 (92.7)
Surgical 886 (7.3)
Pneumonia (%) 2,401 (19.9)
Tuberculosis (%) 2,256 (18.8)
PCP (%) 892 (7.4)
Hepatitis B (%) 483 (4.0)
Hepatitis C (%) 2,896 (24)
Hospital size (beds) 538.3 ± 360.1
Hospital catchment area (%)
Live in 8,998 (74.5)
Live out 3,080 (25.5)
Hospital classification (%)
Central 8,206 (68.0)
Non-central 3,872 (32.0)BMC Health Services Research 2009, 9:125 http://www.biomedcentral.com/1472-6963/9/125
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frailty significantly less than 1. Hospital number 1 (with
frailty significantly less than 1) corresponds to a large
teaching central hospital in a metropolitan area, while
hospital number 43 (with frailty significantly greater than
1) is a non-central hospital in a smaller area.
Discussion
To our knowledge, this is the first paper that applies hier-
archical modelling to account for hospital and individual
characteristics among HIV/AIDS discharges in Portugal.
Risk factors for mortality in the frailty model included
male gender, older age, urgent admission, medical DRG,
a higher number of diagnoses, pneumonia, and admis-
sion to a non-central hospital.
The discharge variables included in the model behaved as
expected. In Portuguese NHS hospitals, as well as in those
of other countries [17,18], men are associated with a
higher risk of death due to HIV/AIDS than are women.
Urgent admission presents the highest hazard ratio. Con-
sidered as a proxy for SES, this finding confirms the results
obtained in previous studies, where patients with urgent
admission are of lower SES when compared to patients
with programmed admission [19,20]. On the contrary, we
find that surgical hospitalizations yield the lowest risk
rates, reducing the risk of death by 44%. This result was
somehow expected since the patients hospitalized to sur-
gical procedures usually have a well established clinical
situation, better than a patient with a non-surgical hospi-
talization. In consonance with, the double percentage of
planned admission in surgical hospitalization compared
with the one in non-surgical hospitalization can be used
to strengthen this hypothesis. We also have to consider
the fact that DRG data is designed to be a financial system
which determines how hospital will be reimbursed. The
predetermined DRG reimbursement is based on principal
KM estimates of survival for selected variables: gender, age, type of admission and type of DRG Figure 2
KM estimates of survival for selected variables: gender, age, type of admission and type of DRG.BMC Health Services Research 2009, 9:125 http://www.biomedcentral.com/1472-6963/9/125
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Table 2: Kaplan-Meier survival estimator of 12,078 HIV hospitalizations
Variables Median survival LOS (95% CI) p-value Log Rank test p-value Log Rank test
Gender
Male 75 (69; 80) <0.001 <0.001
Female 84 (73; 104)
Year of discharge
2005 76 (71; 87) 0.357 0.405
2006 78 (69; 100)
2007 75 (68; 88)
Age
≤ 39 92 (83; 104) <0.001 <0.001
> 39 71 (65; 76)
Type of admission
Urgent 75 (69; 80) <0.001 <0.001
Planned 95 (77;-)
Type of DRG
Medical 75 (69; 80) <0.001 <0.001
Surgical 110 (84; 191)
Number of diagnoses
≤ 5 83 (74;-) 0.040 0.080
> 5 75 (69; 80)
Number of procedures
≤ 8 100 (80; 140) 0.175 0.175
> 8 75 (69; 80)
Pneumonia
Yes 53 (48; 59) <0.001 <0.001
No 87 (81; 100)
Tuberculosis
Yes 97 (83; 113) <0.001 <0.001
No 69 (64; 78)
PCP
Yes 87 (78;140) 0.162 0.179
No 76 (71; 83)
Hepatitis B
Yes 80 (50;-) 0.412 0.275
No 77 (73; 83)
Hepatitis C
Yes 80 (75;100) 0.092 0.112
No 76 (70; 83)
Region
North 75 (64; 85) 0.258 0.193
Centre 78 (68; 135)
Lisbon and Tagus valley 78 (70; 84)
South - (74;-)
Distance
≤ 13 km 75 (69; 80) 0.008 0.023
> 13 km 92 (75; 170)
Hospital size
N. beds ≤ 500 76 (70; 84) 0.089 0.078
N. beds > 500 79 (72; 85)
Hospital catchment area
Live in 75 (69;79) 0.009 0.014
Live out 87 (78; 110)
Hospital classification
Central 82 (75; 88) <0.001 <0.001
Non-central 71 (61; 79)BMC Health Services Research 2009, 9:125 http://www.biomedcentral.com/1472-6963/9/125
Page 7 of 10
(page number not for citation purposes)
diagnosis, procedures, patient age and sex, the presence of
complications or comorbidities, surgical intervention
and, discharge type. However, this homogeneous form of
calculating the hospital reimbursement causes serious
financial losses to hospital when the primary mode of
therapy associated with the hospitalization is surgical. A
surgical procedure will imply the use of an operating
room which will have a great influence on the hospital
means used by the patient and in the final costs [21].
Accordingly, the DRG type was introduced in Cox model
to control the effect of DRG case mix.
Pneumonia was also a strong predictor of hospital mortal-
ity in our study. Patients with pneumonia were 1.43 times
more likely to die when compared to those without pneu-
monia. This finding is in accordance with studies from
Europe [22] and North America [23] showing that pneu-
monia is an important predictor of mortality in patients
with HIV/AIDS.
On the other hand, tuberculosis has been associated with
improved survival [24-27]. In our study, tuberculosis was
also associated with better hospital survival, reducing the
risk of death by 22%. This protective effect relies on the
fact that tuberculosis incidence rate (34.4/100,000 inhab-
itants) in Portugal is one of the highest in Europe [28]
and, it is the first disease diagnosed in HIV infection
patients. Therefore, tuberculosis HIV patients are hospital-
ized sooner than other patients and begin HAART treat-
ment earlier.
The issue of whether hepatitis C effects progression of
HIV-disease remains controversial [29]. In the Swiss
Cohort, the presence of hepatitis C was independently
associated with an increased risk of progression to AIDS
and death [30]. However subsequent studies from other
cohorts, did not find any differences in survival when
multivariate analysis was applied. For example, the EuroS-
IDA cohort found no difference between hepatitis C posi-
tive and hepatitis C negative HIV-infected patients [31]. In
our study, hepatitis C is not associated with hospital mor-
tality after adjustment for other covariates.
The number of diagnoses and procedures for a particular
patient express the complications and co-morbidities that
the patient had during hospital stay. A great number of
diagnoses or procedures usually indicates a more severe
condition of the patient [32]. In this analysis only the
number of diagnoses was statistically significant increas-
ing the mortality risk by 2% for each increase in the
number of diagnoses.
Hospital size was measured in terms of number of beds.
Lee and collaborators [33] have shown that efficient hos-
pitals had fewer beds than inefficient hospitals, everything
else being constant. Based on this evidence, we expected
that smaller hospital had a lower risk of death. However,
in our study, hospital size only suggests a statistically sig-
nificant increase in hospital mortality risk in the Cox
Model without frailties.
The present study found that there are significant differ-
ences in hospital mortality due to hospital classification.
The risk of death is reduced by 20% in a central hospital
when compared to a non-central hospital. This finding is
somewhat expected since in Portugal the follow-up of
patients with HIV/AIDS is more frequent in central hospi-
tals, where anonymity is guaranteed; often, patients only
attend non-central health services when they are in a seri-
ous acute situation. Additionally, it is well known that
dedicated AIDS units and management hospitals offer
important benefits to AIDS patients [34] and in Portugal,
central hospitals are the only ones that have communica-
ble diseases department.
Table 3: Cox proportional hazards models for hospital mortality
No frailty Frailty
Variables HR (95% CI) p-value HR (95% CI) p-value
Gender (male) 1.268 (1.13; 1.42) <0.001 1.272 (1.14; 1.43) <0.001
Age (years) 1.013 (1.01; 1.02) <0.001 1.013 (1.01; 1.02) <0.001
Type of admission (urgent) 1.699 (1.43; 2.02) <0.001 1.592 (1.33; 1.91) <0.001
Type of DRG (surgical) 0.569 (0.47; 0.69) <0.001 0.560 (0.46; 0.68) <0.001
Number of diagnoses 1.018 (1.00; 1.03) 0.012 1.020 (1.01; 1.04) 0.012
Number of procedures 0.997 (0.98; 1.01) 0.580 0.994 (0.98;1.01) 0.360
Pneumonia 1.428 (1.29; 1.59) <0.001 1.431 (1.29; 1.59) <0.001
Tuberculosis 0.779 (0.69; 0.88) <0.001 0.783 (0.69; 0.88) <0.001
Hepatitis C 1.013 (0.90; 1.14) 0.820 1.011 (0.90; 1.14) 0.850
Hospital size (>500 beds) 1.118 (1.01; 1.24) 0.033 1.145 (0.93; 1.41) 0.210
Live in catchment area 1.032 (0.92; 1.15) 0.590 1.011 (0.90; 1.14) 0.850
Central hospital 0.798 (0.72; 0.89) <0.001 0.808 (0.68; 0.97) 0.002
Frailty variance 0.032 0.002BMC Health Services Research 2009, 9:125 http://www.biomedcentral.com/1472-6963/9/125
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Living in the catchment hospital area was used as a proxy
of residential distance to hospital based on the evidence
that increased distance was associated with increased risk
of death [35-37]. However, in our study this variable was
not statistically significant in both models.
The frailty model estimated a small variability among hos-
pitals (range 0.67 to 1.34), although it is statistically sig-
nificant. Standard single-level models, usually adopted in
these studies, treat all hospitalizations as independent
observations. Actually, patients are nested in hospitals on
the basis of reasons that lead them to make some choices
(place of residence, trust in a particular doctor, the hospi-
tal's reputation, etc), thus violating one of the basic
assumptions of traditional regression analysis. In hierar-
chical models the random variability of data is divided
into two parts: variation between different hospitaliza-
tions and between different hospitals. The hospital frailty
component should be interpreted as differences in hospi-
tal quality/performance.
Consequently, hierarchical modelling is strongly advo-
cated as a more appropriate statistical method for dealing
with data clustered within hospitals [38-42]. This is the
one of the strengths of our study, taking into account the
hierarchical nature of the DRG data.
The frailty model revealed a variation in risk not resulting
from any of the measured covariates. One possible expla-
nation for this variability might be the differences in hos-
pital accessibility and services availability. Due to the
inexistence of a variable for measuring the accessibility,
one way to incorporate this could be through the investi-
gation of a geographical pattern in the frailty of hospitals
[42,43]. In this study, we used the catchment area, but this
variable was not statistically significant in the frailty
model. Additional research is needed here.
Study limitations
This study, like most studies, has limitations. The DRG
data cannot account for multiple admissions, reducing
Frailty model estimates of HR of hospitals showing the point estimate (circle) and their respective 95% CI band Figure 3
Frailty model estimates of HR of hospitals showing the point estimate (circle) and their respective 95% CI 
band.BMC Health Services Research 2009, 9:125 http://www.biomedcentral.com/1472-6963/9/125
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our experimental unit to discharge episode instead of
patient. It should be stressed that the information on hos-
pital characteristics was gathered for other purposes than
this study and some vital features of HIV/AIDS patients
are missing, such as CD4 counts and viral load [9,44].
Conclusion
The use of DRG data is crucial in comparing different hos-
pitals, patients, and places. Moreover, the frailty model
used in this study proved to be useful for this purpose.
Nonetheless, it is a strong candidate to be a very efficient
tool for the state health authorities, due to software avail-
ability. Accounting for clustering of observations, the
frailty model provides truthful estimates of standard
errors and assures less biased results. Our findings sug-
gested that, for healthcare policy purposes, the hospitals
should not be treated in an equal manner; namely the one
identified as outlier.
For future developments we intend to construct a joint
spatial survival model to investigate factors that affect HIV
hospital mortality and taking into account geographical
factors. This work can contribute to the debate on the eval-
uation of a hospital's performance on HIV treatment.
Also, our results might help hospital managers/practition-
ers understand the major predictors of HIV related mortal-
ity and to look at it in a different way.
Finally, local investigation of higher risk hospitals should
be undertaken in order to disclose factors leading to dif-
ferences in the HIV mortality risk detected in this study.
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